Gritstone bio

About:

Gritstone bio is a biotechnology company that develops immunotherapies for cancer and infectious diseases.

Website: https://gritstonebio.com

Twitter/X: gritstonebio

Top Investors: Hercules Capital, Alexandria Venture Investments, Gilead Sciences, Google Ventures, Lilly Asia Ventures

Description:

Gritstone bio develops immunotherapies for cancer and infectious diseases. They started with tumor-specific neoantigens and their programs to include viral antigens displayed on the surface of the virally infected cells. Their biological immune system recognition of targets on the surface of abnormal cells is common to anti-tumor and anti-viral immunity. With the development and commercialization of immunotherapy drugs including checkpoint inhibitors, the field of immuno-oncology is transforming the treatment of patients with cancer.